CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis
Andrew Dunbar(Memorial Sloan Kettering Cancer Center), Ronald Hoffman(Icahn School of Medicine at Mount Sinai), Anouar Zouak(Memorial Sloan Kettering Cancer Center), Rong Fan(Yale Cancer Center), Julie L. Yang(Memorial Sloan Kettering Cancer Center), Aishwarya Krishnan(Memorial Sloan Kettering Cancer Center), Zhuo Chen, Ross L. Levine(Memorial Sloan Kettering Cancer Center), Mirko Farina(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Jenna Snyder(Memorial Sloan Kettering Cancer Center), Nada Elmansy(Icahn School of Medicine at Mount Sinai), Wenbin Xiao(Memorial Sloan Kettering Cancer Center), Anna Ritá Migliaccio(Altius Institute for Biomedical Sciences), Jayden Yohai(Memorial Sloan Kettering Cancer Center), Richard P. Koche(Massachusetts General Hospital), Timothy McConnell(IsoPlexis (United States)), Keith B. Cordner(Memorial Sloan Kettering Cancer Center), Abdul Karzai(Memorial Sloan Kettering Cancer Center), Raajit K. Rampal(Memorial Sloan Kettering Cancer Center), Jing Zhou(Inner Mongolia Electric Power (China)), Yang Xiao(Columbia University), Dongjoo Kim(Yale University), Jonathan Chen(IsoPlexis (United States)), Paola Verachi(University of Bologna), Erin McGovern, Eric Tucker(IsoPlexis (United States)), Young Joo Park(Sutro Biopharma (United States)), Min Lü(Central South University), Corrine Hill(Memorial Sloan Kettering Cancer Center), Lijuan Xia(Icahn School of Medicine at Mount Sinai), Francesca Gobbo(University of Bologna), Maria Kleppe(Memorial Sloan Kettering Cancer Center), Fabrizio Martelli(Istituto Superiore di Sanità)
Cited by 6
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k